Home > News


Applications are now open for the WHF Salim Yusuf Emerging Leaders Programme 2019

Posted on Monday, 18 February 2019 19:46


The 2019 cohort marks the sixth year of the World Heart Federation (WHF) Emerging Leaders programme and will focus on heart failure. Applications are now open until 24 March.


Created in 2014 by world-renowned leader in global cardiovascular disease (CVD) research and WHF Past President, Professor Salim Yusuf, this WHF initiative is among the first international training programmes on cardiovascular health policy research, health systems and implementation science. Its main objective is to build up capacity, professional development, mentorship, and networking of Emerging Leaders (ELs) worldwide.


The 2019 cohort will focus on heart failure. Previous cohorts have focused on secondary prevention of cardiovascular diseases, raised blood pressure, tobacco prevention and control, access to essential medicines, and stroke.


The World Heart Federation aims to reach as many potential candidates as possible on a global basis. Candidates from academia, civil service, private industry and cardiovascular medicine are encouraged to apply. Candidates may be affiliated with a member organization of the World Heart Federation, but this is not mandatory.


All Emerging Leaders participants will be required to participate in online training, a five-day think tank seminar from 13-18 October 2019 in London, UK, and collaborative group work based on proposals developed during the seminar with seed funding support from the World Heart Federation from meritorious applications.


If you are interested in applying, please visit www.whfel.org and make sure your colleagues and connections are aware of this opportunity. The closing date for applications is 24 March 2019.


For any further queries or information about the programme, please email: emergingleaders@worldheart.org.

Dr Norah Maitisa is new pharma industry representative on SA Heart committee

Posted on Tuesday, 13 November 2018 11:48

SA Heart welcomes Dr Norah Maitisa as the new pharma industry representative on the SA Heart committees, while Mr Rob Millar remains the device industry representative.

Norah Maitisa is a Medical Advisor at MSD South Africa for Lipids, Hypertension, Diabetes and Pain portfolios. She has also previously worked at GSK’s Respiratory and HIV portfolios. She has worked as a Technical advisor in several NGO’s contributing towards government’s primary health care nurse management of HIV/TB and has contributed in PC101 (TB/HIV) formulation within its working groups. Qualified in 2002 from MEDUNSA, also acquired her master in Science in Epidemiology (MSc Epidemiology) from Wits university.


Dr Norah Maitisa.png 335.0K 13 Nov 18 11:48


Posted on Wednesday, 7 November 2018 08:59

Cochrane South Africa, South African Medical Research Council is offering three doctoral scholarships for policy relevant non-communicable disease-related research within the low and middle income countries public health context or evidence-based health care. Applications close on 26 November 2018.


See attached for more information about the scholarship including the application form.


CEBHA+ CSA PhD scholarship - Application Form.docx 373.7K 7 Nov 18 08:59
CEBHA+ CSA PhD scholarship - Call for Applications.pdf 298.3K 7 Nov 18 08:59

Prof Zühlke wins prestigious African Research Leader Award

Posted on Friday, 12 October 2018 17:52

Our immediate past president, Paediatric cardiologist Associate Professor Liesl Zühlke has recently won the prestigious SA Medical Research Council/ UK Department of International Development(MRC/DFID) African Research Leader Award.

Read the full story here in the UCT Faculty of Health Sciences Newsletter.

Viewing page 9 of 9. Records 81 to 84 of 84.